Position in ABBV
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$7,182,560
+$818,586 QoQ
Shares Held
28,543
-2.5% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.03%
of 13F equity value
Holder Rank
#1,089
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SMITH, MOORE & CO. holds $27,430,178 across 9 Drug Manufacturers - General names. ABBV ranks #1 (26.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
28,543 | $7,182,560 | |
| 2 | LLY |
ELI LILLY & Co
|
5,912 | $7,091,030 | |
| 3 | JNJ |
Johnson & Johnson
|
23,180 | $5,887,024 | |
| 4 | MRK |
Merck & Co., Inc.
|
23,976 | $3,080,916 | |
| 5 | AMGN |
Amgen Inc
|
4,729 | $1,712,465 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
15,730 | $906,362 | |
| 7 | PFE |
Pfizer Inc
|
32,201 | $775,400 | |
| 8 | AZN |
Astrazeneca PLC
|
2,644 | $501,355 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,182,560 | 28,543 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $6,363,974 | 29,261 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $6,306,780 | 27,602 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $6,738,740 | 29,104 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $5,322,282 | 28,673 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $6,206,820 | 29,624 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $5,375,602 | 30,251 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $5,956,589 | 30,163 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $5,488,640 | 32,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $6,079,408 | 33,385 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $5,442,391 | 35,119 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $5,347,676 | 35,876 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $4,772,944 | 35,426 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $5,742,101 | 36,030 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $6,127,281 | 37,914 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $5,157,421 | 38,428 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $6,076,010 | 39,671 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $6,565,455 | 40,500 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $5,604,070 | 41,389 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $4,368,411 | 40,497 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $4,529,817 | 40,215 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $4,123,831 | 38,106 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $4,179,707 | 39,008 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $3,356,886 | 38,325 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $3,542,923 | 36,086 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $2,455,451 | 32,228 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||